# Rituximab in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease

> **NCT00003849** · PHASE2 · COMPLETED · sponsor: **Alliance for Clinical Trials in Oncology** · enrollment: 39 (actual)

## Conditions studied

- Lymphoma

## Interventions

- **BIOLOGICAL:** rituximab

## Key facts

- **NCT ID:** NCT00003849
- **Lead sponsor:** Alliance for Clinical Trials in Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-07
- **Primary completion:** 2005-02
- **Final completion:** 2008-02
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2016-07-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003849

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003849, "Rituximab in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00003849. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*